"Studies of the safety and immunogenicity of the combination of the AstraZeneca vaccine and the first component of the Sputnik V vaccine in Azerbaijan began in February 2021, to date, 50 volunteers have been vaccinated, recruitment for the clinical study continues," the statement said.
It is specified that the interim data analysis demonstrates high safety indicators for the combined use of drugs.
The RDIF stressed the absence of serious side effects and cases of coronavirus after vaccination.
On July 26, it became known that the Russian Ministry of Health approved clinical trials of a combination of vaccines against the coronavirus AstraZeneca and Sputnik Light.
Vitaly Zverev, a microbiologist, scientific director of the Mechnikov Research Institute of Vaccines and Serums, Academician of the Russian Academy of Sciences, in an interview with URA.RU, emphasized the importance of achieving population immunity from coronavirus in the world.